The June 1 Ohio Board of Pharmacy summary suspension notice detailed allegations involving unauthorized use of APRN NPI numbers, NAD and sermorelin orders without prescriber authorization, alleged drug storage and recordkeeping violations, and receipt of purported BPC-157.
Ohio Board Details Allegations in Summary Suspension Notice
On June 1, 2026, the Ohio Board of Pharmacy summarily suspended the Terminal Distributor of Dangerous Drugs (TDDD) license held by Pure Health Aesthetics & Wellness in Lewis Center, Ohio. The action followed allegations involving drug sourcing, activities outside the authorized scope of practice, and failures in medication security and clinic operations. For Med Spa and aesthetic operators, the case shows how pharmacy-board enforcement can apply to combined medical and aesthetic practices that purchase, possess, or distribute dangerous drugs regulated under Ohio law.
Board Inspections Identified Alleged Drug Handling and Recordkeeping Violations
The Ohio Board of Pharmacy’s case followed two 2026 inspections of Pure Health Aesthetics & Wellness. The notice describes the business as a combined chiropractic and Med Spa practice that employed APRNs for medical and aesthetic services. During an April 8 inspection and subsequent investigation, Board staff reviewed the clinic’s drug purchasing, prescriber authorization, medication records, and storage practices.
Key allegations in the Board’s notice include:
- Unauthorized prescriber credentials: Clinic owners allegedly used APRN NPI numbers to order NAD and sermorelin without authorization, including after one APRN resigned and while another was outside the country.
- Missing prescriber orders: The Board identified multiple instances in which NAD or sermorelin was provided without a documented prescriber order. It also alleged that a clinic owner gave dosing recommendations to a patient who later lost consciousness after using NAD.
- Returned medications: NAD and sermorelin returned by one patient were allegedly later provided for another patient’s use.
- Drug sourcing: On May 13, the clinic received two vials represented as BPC-157 from Alpha Biomed, which the Board said lacked the U.S. drug-distribution or manufacturing credentials identified in the notice.
- Drug security and records: Inspectors reported issues involving controlled-substance access, multidose vials, temperature monitoring, inventories, purchasing records, and medication documentation.
A May 27 follow-up inspection identified additional issues involving expired multidose vials, medication records, and refrigerator security. The Board summarily suspended the clinic’s TDDD license on June 1, 2026. As of this reporting, the license remains listed as inactive and suspended.
Ohio Board of Pharmacy Summary Suspension Notice
According to the June 1, 2026, Ohio Board of Pharmacy Summary Suspension/Notice of Opportunity for Hearing involving Pure Health Aesthetics & Wellness, Case No. A-2026-0164, the Board summarily suspended the clinic’s Terminal Distributor of Dangerous Drugs license and detailed allegations identified through its inspections and investigation.
Ohio Compliance Considerations for Drug Sourcing, Dispensing, and Provider Oversight
The Ohio case involves several compliance concerns surrounding medication handling within a combined chiropractic and Med Spa clinic. The Board alleged unauthorized use of prescriber credentials, missing prescriber orders and records, improper drug sourcing, and failures involving medication security. Under ORC 4729.55 and OAC 4729:5-2-01(E)(6), the licensed facility and responsible person are accountable for supervision and control of dangerous drugs.
Drug sourcing was another major focus. ORC 4729.51(F) limits wholesale purchases of dangerous drugs to authorized entities, while ORC 4729.60(B) requires a terminal distributor to verify a seller through the Board’s roster. The notice tied those requirements to the May 13 shipment of purported BPC-157 from Alpha Biomed, which the Board said lacked the U.S. drug-distribution or manufacturing credentials identified in the notice.
The Board also alleged that NAD and sermorelin were ordered using APRN credentials without authorization, provided without documented prescriber orders, and that returned medication was later used for another patient. Inspectors reported opened or expired multidose vials and unsecured medication storage. Similar provider-authority concerns appeared in an Iowa nursing license suspension involving a health spa ARNP and an Arizona enforcement case involving alleged unlicensed cosmetic injections. For Med Spa operators, medication services should align with provider authority, verified sourcing, secure storage, and complete records.
Ohio’s TDDD requirements make medication control a responsibility of both the licensed facility and its designated responsible person.
Practical Implications for Ohio Med Spa Operators Handling Medications
- Verify wholesale drug suppliers through the Ohio Board of Pharmacy roster before purchasing dangerous drugs, as required under ORC 4729.60(B).
- Match Med Spa medication services, including injectable or take-home drugs, with the applicable prescribing and administration authority required.
- Document prescriber orders and medication administration as aligned with OAC 4729:5-19-04 when regulated drugs are used in patient care.
- Secure medications kept on-site for aesthetic, wellness, or other clinical services under the storage and access requirements cited in OAC 4729:5-19-03.
- Maintain required inventories, purchasing records, responsible-person records, and medication documentation for the licensed clinic.
What to Watch Next
The June 1 notice gave Pure Health Aesthetics & Wellness 30 days from the date of service to request a hearing before the Ohio Board of Pharmacy. As of this reporting, the TDDD license remains suspended. For Med Spa operators, the case involves medication requirements that may apply in aesthetic and wellness settings, including prescriber authorization, drug sourcing, storage, and required records.
About Spakinect
Spakinect provides compliance infrastructure and telehealth-supported supervision solutions for medical aesthetic practices. For additional information, see our website.
Image Attribution: “Ohio State Office Building Wide 1” by Sixflashphoto, via Wikimedia Commons, licensed under CC BY-SA 4.0.
